European Journal of Immunology

Cellular and molecular mechanisms of anti‐fungal innate immunity at epithelial barriers: the role of C‐type lectin receptors

Immune checkpoint molecules in pregnancy: Focus on regulatory T cells

CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma

Bcl6 modulates innate immunity by controlling macrophage activity and plays critical role in experimental autoimmune encephalomyelitis

Presence, function, and regulation of IL‐17F‐expressing human CD4+ T cells

Neutrophils suppress mucosal‐associated invariant T cells in humans

Overexpression of GILZ in macrophages limits systemic inflammation while increasing bacterial clearance in sepsis in mice

cDC2 and plasmacytoid dendritic cells diminish from tissues of patients with non‐Hodgkin orbital lymphoma and idiopathic orbital inflammation

CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity

Identifying the inheritable component of human thymic T cell repertoire generation in monozygous twins

Immunology Letters

Effects of yolkin on the immune response of mice and its plausible mechanism of action

Analysis of the frequency of type 2 innate lymphoid cells and regulatory T cells in abortion-prone mice

Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis

Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype

Immunoregulatory properties of mesenchymal stem cells: Micro-RNAs

Outer membrane vesicle increases the efficacy of an influenza vaccine in a diet-induced obese mouse model

Targeting ROCK signaling in health, malignant and non-malignant diseases

Prohibitin 1 interacts with signal transducer and activator of transcription 3 in T-helper 17 cells

Activation-induced surface proteins in the identification of antigen-responsive CD4 T cells

Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy